Search - tctmd.com

Displaying 321 - 340 of 360

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2016

Con Qué Me Quedo de TCT 2016: Sorpresas, Presuposiciones y Revelaciones

Shelley Wood

November 07, 2016

News Industry News TCT 2016

Long-Term Study Results Show that PFO Closure is More Effective Than Medical Management in Preventing Recurrent Stroke

November 01, 2016

News Conference News TCT 2016

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

Yael L. Maxwell

November 01, 2016

Presentation TCT 2016

RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke

Presenter: Howard C. Herrmann, Robert J. de Winter, David E. Thaler

November 01, 2016

‘Promising’ SENTINEL Cerebral Protection in TAVR Collects Debris but Misses Primary Endpoint

News Conference News TCT 2016

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

Shelley Wood

November 01, 2016

Presentation TCT 2016

Case Resolution: How Did We Treat this Patient?

Presenter: Nick Curzen, Michael Mahmoudi

October 31, 2016

Presentation TCT 2016

TAVR Restenosis: Review of the Literature

Presenter: Nick Curzen

October 31, 2016

Presentation TCT 2016

Case Introduction: An 87 Year Old Woman With Recurrent Dyspnea 7 Years After TAVR

Presenter: Nick Curzen, Michael Mahmoudi

October 31, 2016

Presentation TCT 2016

TAVR for Intermediate-Risk and Low-Risk Patients: Review of the Literature

Presenter: Niall T. Mulvihill, Michael Mahmoudi

October 31, 2016

Presentation TCT 2016

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Con Position

Presenter: Niall T. Mulvihill, Hellmuth Weich

October 31, 2016

Presentation TCT 2016

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Pro Position

Presenter: Niall T. Mulvihill, Antoniette Neylon

October 31, 2016

Presentation TCT 2016

Introduction: TAVR in Intermediate-Risk and Low-Risk With Severe Aortic Stenosis

Presenter: Niall T. Mulvihill

October 31, 2016

Presentation TCT 2016

Simultaneous TAVR and Endovascular Aortic Aneurysm Repair

Presenter: Habib Gamra, Mahmoud Hashemian, Abdullah Shehab, Walid Ouertani

October 30, 2016

News Conference News TCT 2016

Transcaval TAVR Presents New Option for Patients With Complex Anatomy

Yael L. Maxwell

October 29, 2016

Podcast Heart Sounds

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Shelley Wood

October 24, 2016

News Daily News

New ‘Rapid Recommendations’ Tackle TAVR in Patients at Low-to-Intermediate Risk

Todd Neale

September 29, 2016

News Conference News ESC 2016

Valve Thrombosis After TAVR Linked to Larger Device Size, Lack of Warfarin Therapy

Todd Neale

September 02, 2016

News Daily News

Mortality Risk High in TAVR Patients Who Require Mechanical Circulatory Support

Todd Neale

August 25, 2016

News Daily News

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

Yael L. Maxwell

August 10, 2016

Advertisement

Con Qué Me Quedo de TCT 2016: Sorpresas, Presuposiciones y Revelaciones

Long-Term Study Results Show that PFO Closure is More Effective Than Medical Management in Preventing Recurrent Stroke

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

Case Resolution: How Did We Treat this Patient?

TAVR Restenosis: Review of the Literature

Case Introduction: An 87 Year Old Woman With Recurrent Dyspnea 7 Years After TAVR

TAVR for Intermediate-Risk and Low-Risk Patients: Review of the Literature

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Con Position

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Pro Position

Introduction: TAVR in Intermediate-Risk and Low-Risk With Severe Aortic Stenosis

Simultaneous TAVR and Endovascular Aortic Aneurysm Repair

Transcaval TAVR Presents New Option for Patients With Complex Anatomy

Top Stories in Cardiology: October 2016

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

New ‘Rapid Recommendations’ Tackle TAVR in Patients at Low-to-Intermediate Risk

Valve Thrombosis After TAVR Linked to Larger Device Size, Lack of Warfarin Therapy

Mortality Risk High in TAVR Patients Who Require Mechanical Circulatory Support

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content